The global demand for Oncology Molecular Diagnostics Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Oncology molecular diagnostics is a laboratory diagnosis which relies on the detection of individual biologic molecules. It is used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major cancers diagnosed and treated by molecular diagnostics are breast, ovarian, colorectal, brain, prostate cervical, head and neck, pancreatic, lung, and endometrial cancers.
Growing prevalence of cancer across the world is driving the growth of the market. Cancer is the second leading cause of death worldwide, contributed to an estimated 9.6 million deaths in 2018. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Lung, breast, colorectal, prostate, skin cancers are among the most common cancers. The emergence of practical applications of molecular oncology is largely attributed to the development of user-friendly methods of molecular analysis. Growing collaborations has helped overcome barriers imposed by costs and regulatory requirements. However, incomplete disease knowledge, lack of awareness, little intellectual property protection, an uncertain regulatory environment, and no guarantee of reimbursement is hampering the growth of the market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of oncology molecular diagnostics.
The entire oncology molecular diagnostics market has been sub-categorized into type, product and technology. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Liver Cancer
- Lung Cancer
- Blood Cancer
- Kidney Cancer
- Multiplex PCR
- In Situ Hybridization
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips & Microarrays
- Mass Spectrometry
- Transcription Mediated Amplification
This section covers regional segmentation which accentuates on current and future demand for oncology molecular diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Europe Oncology Molecular Diagnostics Market By Revenue (USD MN)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oncology molecular diagnostics market include Cepheid, Beckton Dickinson, Gen Probe (Hologic), Qiagen, Roche Diagnostics, Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.